Évolution des stents pour le traitement des lésions de l'artère fémorale superficielle

Translated title of the contribution: Evolution of stents for the treatment of femoral artery lesions

A. Lejay, F. Thaveau, C. Bajcz, Y. Georg, J. G. Kretz, B. Durand, N. Chakfé

Research output: Contribution to journalShort surveypeer-review


Endovascular treatment and stent implantation in the superficial femoral artery have been proposed for over 20 years. However, the first experiments with stainless stents were relatively disappointing. The first improvement consisted in the introduction of nitinol self-expanding stents. This technology allowed an initial improvement of clinical performances, but the first generation of nitinol stents demonstrated a relatively high rate of fractures. Better knowledge of the femoral artery biomechanics and advances in technology allowed to propose a second generation of nitinol stents with improved flexibility, which decreased the rates of fracture. In-stent restenosis related to neointimal hyperplasia has also led to the development of new concepts to improve patency rates after stenting of the femoral artery: drug-eluting stents (coated-stents), biodegradable stents, and covered stents. These technologies will help to treat more complex lesions of the femoral artery in the future, with comparable results to those obtained with femoropopliteal bypasses, but we are still waiting for results of ongoing studies.

Translated title of the contributionEvolution of stents for the treatment of femoral artery lesions
Original languageFrench
Pages (from-to)169-173
Number of pages5
JournalJournal des Maladies Vasculaires
Issue number3
StatePublished - Jun 2011


  • Endovascular treatment
  • Femoral artery
  • Stent

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Evolution of stents for the treatment of femoral artery lesions'. Together they form a unique fingerprint.

Cite this